Retraction

Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells in vitro

Paper Information

Record ID:
38699
Publication Date:
November 16, 2021
Retraction Date:
August 23, 2022 (3.2 years years ago)
Article Type:
Publisher:
SAGE Publications
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1177/09603271221076714

Citations (0)

0
Total Citations
0
Post-Retraction
0
Pre-Retraction
0
Same Day
No citations found for this paper.
Quick Stats
Total Citations: 0
Years Since Retraction: 3.2 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Rosiglitazone, a ligand of the peroxisome proliferator-acti…
European Journal of Pharmacology • 217 citations
Role of mitochondria in doxorubicin-mediated cardiotoxicity…
Cell Stress and Chaperones • 10 citations
3,4-Methylenedioxymethamphetamine causes retinal damage in …
Human and Experimental Toxicology • 4 citations
Effect of steviol, steviol glycosides and stevia extract on…
Molecular and Cellular Endocrinology • 29 citations
Sulforaphane triggers iron overload-mediated ferroptosis in…
Human and Experimental Toxicology • 7 citations